AbsEn.i
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « identify »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
identified < identify < identifying  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000017 (2020) Franziska Düver [Allemagne] ; Benedikt Wei Brich [Allemagne] ; Matthias Eyrich [Allemagne] ; Matthias Wölfl [Allemagne] ; Paul G. Schlegel [Allemagne] ; Verena Wiegering [Allemagne]Viral reactivations following hematopoietic stem cell transplantation in pediatric patients – A single center 11-year analysis
000080 (2020) Maria Valeria Catani ; Isabella Savini ; Valentina Tullio ; Valeria GasperiThe “Janus Face” of Platelets in Cancer
000102 (2020) Xiaoyan He [République populaire de Chine] ; Qingyan Ma [République populaire de Chine] ; Yajuan Fan [République populaire de Chine] ; Binbin Zhao [République populaire de Chine] ; Wei Wang [République populaire de Chine] ; Feng Zhu [République populaire de Chine] ; Xiancang Ma [République populaire de Chine] ; Lina Zhou [République populaire de Chine]The Role of Cytokines in Predicting the Efficacy of Acute Stage Treatment in Patients with Schizophrenia
000137 (2020) Gui Wang ; Xiao-Rong Jin ; De-Xun JiangSuccessful treatment of adult-onset still disease caused by pulmonary infection-associated hemophagocytic lymphohistiocytosis: A case report
000156 (2020) Shuichiro Nakabo [Japon] ; Yuko Tsuji [Japon] ; Maiko Inagaki [Japon] ; Hideaki Tsuji [Japon] ; Toshiki Nakajima [Japon] ; Kosaku Murakami [Japon] ; Chikashi Terao [Japon] ; Motomu Hashimoto [Japon] ; Moritoshi Furu [Japon] ; Masao Tanaka [Japon] ; Hiromu Ito [Japon] ; Takao Fujii [Japon] ; Tsuneyo Mimori [Japon] ; Yasutomo Fujii [Japon]Severe joint deformity and Patient Global Assessment of Disease are associated with discrepancies between sonographic and clinical remission: A cross-sectional study of rheumatoid arthritis patients.
000180 (2020) Emily Yi-Chih Ting ; Albert C. Yang [États-Unis] ; Shih-Jen Tsai [Taïwan]Role of Interleukin-6 in Depressive Disorder
000213 (2020) Ludivine Renaud [États-Unis] ; Willian A. Da Silveira [Royaume-Uni] ; Naoko Takamura [États-Unis] ; Gary Hardiman [États-Unis, Royaume-Uni] ; Carol Feghali-Bostwick [États-Unis]Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis
000220 (2020) Jamie E. Collins ; Fredrik D. Johansson ; Sara Gale ; Seoyoung Kim ; Swastina Shrestha ; David Sontag ; Jacklyn Stratton ; Huong Trinh ; Chang Xu ; Elena Losina ; Daniel H. SolomonPredicting Remission Among Patients With Rheumatoid Arthritis Starting Tocilizumab Monotherapy: Model Derivation and Remission Score Development
000273 (2020) Zheng Wang [États-Unis] ; Yicheng Zhao [États-Unis] ; Zhiqiang An [États-Unis] ; Wenliang Li [États-Unis]Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression
000375 (2020) Helga Ellingsgaard [Danemark] ; Eleonora Seelig [Suisse] ; Katharina Timper [Suisse] ; Michael Coslovsky [Suisse] ; Line Soederlund [Danemark] ; Mark P. Lyngbaek [Danemark] ; Nicolai J. Wewer Albrechtsen [Danemark] ; Arno Schmidt-Trucks Ss [Suisse] ; Henner Hanssen [Suisse] ; Walter O. Frey [Suisse] ; Kristian Karstoft [Danemark] ; Bente K. Pedersen [Danemark] ; Marianne Böni-Schnetzler [Suisse] ; Marc Y. Donath [Suisse]GLP-1 secretion is regulated by IL-6 signalling: a randomised, placebo-controlled study.
000412 (2020) Sathana Ingaralingam [Royaume-Uni] ; Saaeha Rauz [Royaume-Uni] ; Philip I. Murray [Royaume-Uni] ; Robert J. Barry [Royaume-Uni]Effectiveness of pharmacological agents for the treatment of non-infectious scleritis: a systematic review protocol
000435 (2020) Dianna Wolfe [Canada] ; Salmaan Kanji [Canada] ; Fatemeh Yazdi [Canada] ; Pauline Barbeau [Canada] ; Danielle Rice [Canada] ; Andrew Beck [Canada] ; Claire Butler [Canada] ; Leila Esmaeilisaraji [Canada] ; Becky Skidmore [Canada] ; David Moher [Canada] ; Brian Hutton [Canada]Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations
000448 (2020) Martina Bonacini [Italie] ; Alessandra Soriano [Italie] ; Luca Cimino [Italie] ; Luca De Simone [Italie] ; Elena Bolletta [Italie] ; Fabrizio Gozzi [Italie] ; Francesco Muratore [Italie] ; Maria Nicastro [Italie] ; Lucia Belloni [Italie] ; Alessandro Zerbini [Italie] ; Luigi Fontana [Italie] ; Carlo Salvarani [Italie] ; Stefania Croci [Italie]Cytokine Profiling in Aqueous Humor Samples From Patients With Non-Infectious Uveitis Associated With Systemic Inflammatory Diseases
000552 (2020) Tomasz J. Guzik [Royaume-Uni] ; Saidi A. Mohiddin [Royaume-Uni] ; Anthony Dimarco [Royaume-Uni] ; Vimal Patel [Royaume-Uni] ; Kostas Savvatis [Royaume-Uni] ; Federica M. Marelli-Berg [Royaume-Uni] ; Meena S. Madhur [États-Unis] ; Maciej Tomaszewski [Royaume-Uni] ; Pasquale Maffia [Royaume-Uni] ; Fulvio D'Acquisto [Royaume-Uni] ; Stuart A. Nicklin [Royaume-Uni] ; Ali J. Marian [États-Unis] ; Ryszard Nosalski [Royaume-Uni] ; Eleanor C. Murray [Royaume-Uni] ; Bartlomiej Guzik [Pologne] ; Colin Berry [Royaume-Uni] ; Rhian M. Touyz [Royaume-Uni] ; Reinhold Kreutz [Allemagne] ; Dao Wen Wang [République populaire de Chine] ; David Bhella [Royaume-Uni] ; Orlando Sagliocco [Italie] ; Filippo Crea [Italie] ; Emma C. Thomson [Royaume-Uni] ; Iain B. Mcinnes [Royaume-Uni]COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options.
000634 (????) Feng Zhu [République populaire de Chine] ; Guoqing Wei [République populaire de Chine] ; Mingming Zhang [République populaire de Chine] ; Houli Zhao [République populaire de Chine] ; Wenjun Wu [République populaire de Chine] ; Luxin Yang [République populaire de Chine] ; Yongxian Hu [République populaire de Chine] ; He Huang [République populaire de Chine]Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "identify" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "identify" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    identify
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021